Lv21
180 积分 2024-03-05 加入
The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention
9小时前
已完结
Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier
14天前
已完结
TROP-2 directed antibody-drug conjugates (ADCs): The revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC)
28天前
已完结
Datopotamab Deruxtecan: First Approval
29天前
已完结
B-cell depletion in autoimmune diseases
1个月前
已完结
Datopotamab Deruxtecan: First Approval
1个月前
已关闭
Scientific and Regulatory Policy Committee Points to Consider: Review of the United States Food and Drug Administration (FDA) Guidance on Pathology Peer Review in Nonclinical Toxicology Studies
3个月前
已完结
Immunopathogenesis of systemic lupus erythematosus: An update
4个月前
已完结
A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor–Resistant Lung Tumors
7个月前
已完结
Sepsis-Induced Lung Injury: The Mechanism and Treatment
7个月前
已完结
皖公网安备34019202002308
